Vanda Pharmaceuticals Inc. Gains 41.49%
Mon, Feb 23, 2026 at 07:28 PM
Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) shot up at $8.15, a gain of 41.5%. On Mon, Feb 23, 2026, VNDA:NASDAQ hit a New 2-Week High of $8.15. The stock appeared on our News Catalysts scanner on Mon, Feb 23, 2026 at 10:41 AM in the 'BIOTECH' category. From Mon, Feb 09, 2026, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed, Dec 31, 2025 at $9.6 with a volume of 23M+.
About Vanda Pharmaceuticals Inc. (VNDA:NASDAQ)
Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.
Top 10 Gainers:
- Arcellx, Inc. (ACLX:NASDAQ), 77.43%
- Tian Ruixiang Holdings Ltd (TIRX:NASDAQ), 72.73%
- Signing Day Sports, Inc. (SGN:NYSEMKT), 62.47%
- Klotho Neurosciences, Inc. (KLTO:NASDAQ), 62.25%
- Allurion Technologies Inc. (ALUR:NYSE), 60.55%
- J-Star Holding Co. Ltd. (YMAT:NASDAQ), 56.8%
- Reliance Global Group Inc. (EZRA:NASDAQ), 43.07%
- Vanda Pharmaceuticals Inc. (VNDA:NASDAQ), 41.49%
- Jyong Biotech Ltd. (MENS:NASDAQ), 35.82%
- Star Fashion Culture Holdings Limited (STFS:NASDAQ), 28.21%